Evidence map›Paper›PMID 26113082›Full record

ArticleJournal of nanobiotechnology2015

Detection of residual rifampicin in urine via fluorescence quenching of gold nanoclusters on paper.

Krishnendu Chatterjee, Chiung Wen Kuo, Ann Chen, Peilin Chen

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Journal of nanobiotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Krishnendu ChatterjeeDepartment of Engineering and System Science, National Tsing Hua University, Hsinchu, 300, Taiwan. sanu.hit@gmail.com.
Chiung Wen KuoResearch Center for Applied Sciences, Academia Sinica, Taipei, 115, Taiwan, ROC. kuo55@gate.sinica.edu.tw.
Ann ChenDepartment of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. doc31717@ndmctsgh.edu.tw.
Peilin ChenResearch Center for Applied Sciences, Academia Sinica, Taipei, 115, Taiwan, ROC. peilin@gate.sinica.edu.tw.
Research Center for Applied Science, Academia Sinica · TWNational Tsing Hua University · TWTri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRifampicin or rifampin (R) is a common drug used to treat inactive meningitis, cholestatic pruritus and tuberculosis (TB), and it is generally prescribed for long-term administration under regulated dosages. Constant monitoring of rifampicin is important for controlling the side effects and preventing overdose caused by chronic medication. In this study, we present an easy to use, effective and less costly method for detecting residual rifampicin in urine samples using protein (bovine serum albumin, BSA)-stabilized gold nanoclusters (BSA-Au NCs) adsorbed on a paper substrate in which the concentration of rifampicin in urine can be detected via fluorescence quenching. The intensity of the colorimetric assay performed on the paper-based platforms can be easily captured using a digital camera and subsequently analyzed.

resultsThe decreased fluorescence intensity of BSA-Au NCs in the presence of rifampicin allows for the sensitive detection of rifampicin in a range from 0.5 to 823 µg/mL. The detection limit for rifampicin was measured as 70 ng/mL. The BSA-Au NCs were immobilized on a wax-printed paper-based platform and used to conduct real-time monitoring of rifampicin in urine.

conclusionWe have developed a robust, cost-effective, and portable point-of-care medical diagnostic platform for the detection of rifampicin in urine based on the ability of rifampicin to quench the fluorescence of immobilized BSA-Au NCs on wax-printed papers. The paper-based assay can be further used for the detection of other specific analytes via surface modification of the BSA in BSA-Au NCs and offers a useful tool for monitoring other diseases.

Indexed as

AnimalsAntibiotics, AntitubercularBiosensing TechniquesCattleGoldHumansLimit of DetectionMetal NanoparticlesPaperPoint-of-Care SystemsRifampinSerum Albumin, BovineSpectrometry, FluorescenceAntibiotics, AntitubercularGoldRifampinSerum Albumin, Bovine

Identifiers

PMID26113082
PMCPMC4482266
OpenAlexW2147421906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.